Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients? ; volume:16 ; number:1 ; day:18 ; month:11 ; year:2016 ; pages:1-11 ; date:12.2016
BMC cancer ; 16, Heft 1 (18.11.2016), 1-11, 12.2016
- Creator
-
Schirosi, Laura
- Contributor
-
Strippoli, Sabino
Gaudio, Francesca
Graziano, Giusi
Popescu, Ondina
Guida, Michele
Simone, Giovanni
Mangia, Anita
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2951-4
- URN
-
urn:nbn:de:1111-201612097552
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schirosi, Laura
- Strippoli, Sabino
- Gaudio, Francesca
- Graziano, Giusi
- Popescu, Ondina
- Guida, Michele
- Simone, Giovanni
- Mangia, Anita
- SpringerLink (Online service)
Other Objects (12)
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas
Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma
BRAF V600E Metastatic Melanoma Journey: A Perspective from a Patient and his Oncologist
Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Concurrent involvement of the bone marrow by BRAF V600E–mutant melanoma and hairy cell leukemia
Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032
BRAF V600E Expression Is Homogenous and Associated with Nonrecurrent Disease and Better Survival in Primary Melanoma
In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAF V600E in melanoma
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas
Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma
BRAF V600E Metastatic Melanoma Journey: A Perspective from a Patient and his Oncologist
Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Concurrent involvement of the bone marrow by BRAF V600E–mutant melanoma and hairy cell leukemia
Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032
BRAF V600E Expression Is Homogenous and Associated with Nonrecurrent Disease and Better Survival in Primary Melanoma
In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAF V600E in melanoma
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas
Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma
BRAF V600E Metastatic Melanoma Journey: A Perspective from a Patient and his Oncologist
Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Concurrent involvement of the bone marrow by BRAF V600E–mutant melanoma and hairy cell leukemia
Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032
BRAF V600E Expression Is Homogenous and Associated with Nonrecurrent Disease and Better Survival in Primary Melanoma
In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAF V600E in melanoma
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie